Back to search

Article

The MUSCLE-GLP1-CKD study: design and rationale of a prospective real-world cohort evaluating muscle health during GLP-1 receptor agonist therapy in chronic kidney disease and type 2 diabetes

2026-07-23

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> Sarcopenia and impaired physical function are clinically relevant complications of chronic kidney disease (CKD). Patients with CKD and type 2 diabetes mellitus (T2DM) are particularly vulnerable to muscle impairment because of insulin resistance, inflammation, obesity, nutritional abnormalities, multimorbidity and reduced physical activity. Glucagon-like pepti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a5ef2ba9-0d71-55aa-a9d3-cbcfc37ac11f
DOI
10.21203/rs.3.rs-10372706/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The MUSCLE-GLP1-CKD study: design and rationale of a prospective real-world cohort evaluating muscle health during GLP-1 receptor agonist therapy in chronic kidney disease and type 2 diabetesDOI 10.21203/rs.3.rs-10372706/v1
Select a neighboring publication to make it the new centre.